Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma

ONCOLOGY

Volumn 13, Issue 7 SUPPL., 1999, Pages 64-68

  Kim, Yeul Hong ^a   Kim, Byung Soo ^a   Seo, Jae Hong ^a   Choi, Cheol Won ^a   Kim, Jae Sun ^a   Chun, Hoon Jai ^a   Hyun, Jin Hai ^a   Kim, Jun Suk ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FOLINATE CALCIUM;

ADULT; ADVANCED CANCER; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PHASE 2 CLINICAL TRIAL; STOMACH CARCINOMA; TUMOR LOCALIZATION; VOMITING; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CISPLATIN; DRUG ADMINISTRATION ROUTES; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0011550492     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1994. CA Cancer J Clin 44:7-26, 1994.
2. Wilke H, Preusser P, Fink U, et al: New developments in the treatment of gastric carcinoma. Semin Oncol 17(suppl 2):61-70, 1990.
3. Findlay M, Cunningham D: Chemotherapy of carcinoma of the stomach. Cancer Treat Rev 19:29-44, 1993.
4. Cullinan SA, Moertel CG, Fleming TR, et al: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. JAMA 253:2061-2067, 1985.
5. Wils JA, Klein HO, Wagener DJ, et al: Sequential high-dose methotrexate and fluorouracil combined with doxorubicin: A step ahead in the treatment of advanced gastric cancer. A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Study. J Clin Oncol 9:827-831, 1991.
6. Cocconi G, Bella M, Zironi S, et al: Fluorouracil, doxorubicin, and mitomycin combina- tion versus PELF chemotherapy in advanced gastric cancer: A prospective randomized trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 12:2687-2693, 1994.
7. Cunningham D, Cahn A, Menzies-Gow N, et al: Epirubicin, cisplatin and 5-fluorouracil (ECF) is highly effective in advanced gastric cancer (abstract). Proc Am Soc Clin Oncol 9:123, 1990.
8. McDonald J: Gastric cancer: Chemotherapy of advanced disease. Hematol Oncol 10:37-42, 1992.
9. Machover D, Goldschmidt E, Chollet P, et al: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. J Clin Oncol 4:685-696, 1986.
10. Beer M, Cocconi G, Ceci G, et al: A phase II study of cisplatin in advanced gastric cancer. Eur J Cancer Clin Oncol 19:717-720, 1983.
11. Cerasimo RJ, Hong WK: Epirubicin: A review of the pharmacology and adverse effects of an Adriamycin analogue. J Clin Oncol 4:425- 434, 1986.
12. Etienne MC, Bernard S, Fischel JL, et al: Dose reduction without loss of efficacy of 5- fluorouracil and cisplatin combined with folinic acid: In vitro studies on human head and neck carcinoma cell lines. Br J Cancer 63:372-377, 1991.
13. Kyoto Research Group for Chemotherapy of Gastric Cancer: Randomized, comparative study of combination chemotherapy in advanced gastric cancer: 5-Fluorouracil and cisplatin (FP) versus 5-fluorouracil, cisplatin and 4′-epirubicin (FPEPIR). Anticancer Res 12:1983-1988, 1992.
14. Cocconi G: Chemotherapy of advanced gastric carcinoma: To be completely rewritten? Ann Oncol 5:8-11, 1994.
15. Lokich JJ, Ahlgren JD, Gullo JJ, et al: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program study. J Clin Oncol 7:425-432, 1989.
16. Webb A, Cunningham D, Scarffe JH, et al: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15:261-267, 1997.
17. Muggia FM, Jeffers S, Leichman CG, et al: Potential for uracil + Ftorafur (UFT) to mimic protracted infusions of 5-fluorouracil (FU) (abstract). Proc Am Soc Clin Oncol 11:135, 1992.
18. Kim YH, Shin SW, Kim BS, et al: Oral UFT and leucovorin in patients with advanced gastric carcinoma. Oncology 11 (suppl 10):119- 123, 1997.
19. Miller AB, Hoogstraten B, Staquest M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981.
20. Findlay M, Cunningham D, Norman A, et al: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5:609-616, 1994.
21. Zaniboni A, Barni S, Labianca R, et al: Epirubicin, cisplatin, and continuous infusion 5- fluorouracil is an active and safe regimen for patients with advanced gastric cancer: An Italian Group of the Study of Digestive Tract Can- cer (GISCAD) Report. Cancer 76:1694-1699, 1995.
22. Bamias A, Hill ME, Cunningham D, et al: Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival. Cancer 77:1978-1985, 1996.
23. Fraile RJ, Baker LH, Buroker TR, et al: Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223-2228, 1980.
24. Lokich J, Bothe A, Fine N, et al: Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 48:2565-2568, 1981.
25. Ho DH, Pazdur R, Covington W, et al: Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1 -(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4:2085-2088, 1998.
26. Scanlon KJ, Newman EM, Lu Y, et al: Biochemical basis for cisplatin and 5-fluorouracil in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83:8923-8925, 1986.
27. Brambilla C, Rossi A, Bonfante V, et al: Phase II study of doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Res 70:261- 266, 1986.
28. Moertel CG: The natural history of advanced gastric cancer. Surg Gynecol Obstet 126:1071-1074, 1968.
29. Bedikian AY, Chen TT, Khankhanian N, et al: The natural history of gastric cancer and prognostic factors influencing survival. J Clin Oncol 2:305-310, 1984.